Francesc Font-Clos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Francesc Font-Clos has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Caterina Anna Maria La Porta
Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan
1 shared publication - Filippo Cola
Center for Complexity and Biosystems, Department of Physics, University of Milan, Via Celoria 16, 20133 Milano, Italy
1 shared publication - Guido Tiana
Università Degli Studi di Milano and INFN
1 shared publication - Maria Chiara Lionetti
Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, via Celoria 26, 20133 Milano, Italy
1 shared publication - Maria Rita Fumagalli
Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, via Celoria 26, 20133 Milano, Italy
1 shared publication - Marina Camera
Centro Cardiologico Monzino IRCCS, Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 8 August 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (8) , 2573
MicroRNA-222 Regulates Melanoma Plasticity
Melanoma is one of the most aggressive and highly resistant tumors. Cell plasticity in melanoma is one of the main culprits behind its metastatic capabilities. The detailed molecular mechanisms controlling melanoma plasticity are still not completely understood. Here we combine mathematical models of phenotypic switching with experiments on IgR39 human melanoma cells to identify possible key targets to impair phenotypic switching. Our mathematical model shows that a cancer stem cell subpopulation within the tumor prevents phenotypic switching of the other cancer cells. Experiments reveal that hsa-mir-222 is a key factor enabling this process. Our results shed new light on melanoma plasticity, providing a potential target and guidance for therapeutic studies.
- 8 August 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (8) , 2573
Open AccessMicroRNA-222 Regulates Melanoma Plasticity
Melanoma is one of the most aggressive and highly resistant tumors. Cell plasticity in melanoma is one of the main culprits behind its metastatic capabilities. The detailed molecular mechanisms controlling melanoma plasticity are still not completely understood. Here we combine mathematical models of phenotypic switching with experiments on IgR39 human melanoma cells to identify possible key targets to impair phenotypic switching. Our mathematical model shows that a cancer stem cell subpopulation within the tumor prevents phenotypic switching of the other cancer cells. Experiments reveal that hsa-mir-222 is a key factor enabling this process. Our results shed new light on melanoma plasticity, providing a potential target and guidance for therapeutic studies.